Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
This is a well-known CDK4/6 inhibitor that can indirectly inhibit cyclin D3 activity by blocking CDK4 and CDK6, which are required for cyclin D3 to exert its cell cycle-promoting effects. | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
Similar to Palbociclib, Ribociclib is another CDK4/6 inhibitor that indirectly affects cyclin D3 function by inhibiting the CDKs with which cyclin D3 forms complexes. | ||||||
Abemaciclib | 1231929-97-7 | sc-507342 | 10 mg | $110.00 | ||
Abemaciclib is a CDK4/6 inhibitor as well, and it can have an impact on cyclin D3 by targeting the associated CDKs. | ||||||
SNS-032 | 345627-80-7 | sc-364621 sc-364621A | 5 mg 10 mg | $169.00 $262.00 | ||
SNS-032 is a selective inhibitor of CDKs, including CDK2 and CDK7, which can indirectly affect cyclin D3-mediated cell cycle progression. | ||||||
AT7519 | 844442-38-2 | sc-364416 sc-364416A sc-364416B sc-364416C | 5 mg 10 mg 100 mg 1 g | $207.00 $246.00 $1025.00 $3065.00 | 1 | |
AT7519 is a multi-CDK inhibitor with the potential to affect cyclin D3-CDK4/6 complexes. | ||||||
Dinaciclib | 779353-01-4 | sc-364483 sc-364483A | 5 mg 25 mg | $242.00 $871.00 | 1 | |
Dinaciclib is a CDK inhibitor that can target CDK1, CDK2, CDK5, and CDK9, which could indirectly influence cyclin D3 interactions. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol is a CDK9 inhibitor, but it can have broader effects on other CDKs, including those that interact with cyclin D3. | ||||||
PHA-793887 | 718630-59-2 | sc-364580 sc-364580A | 5 mg 10 mg | $189.00 $432.00 | ||
This compound is a CDK inhibitor that can impact various CDKs, including those related to cyclin D3 signaling. |